Biosenta Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZRO.CN research report →
Companywww.biosenta.com
Biosenta Inc. develops, manufactures, and sells anti-microbial chemical compounds for household and industrial applications in Canada. It is involved in developing true, an anti-microbial, dual-action disinfectant that kills viruses, bacteria, mold, and germs on contact.
- CEO
- Amarvir Singh Gill
- IPO
- 2010
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $2.09M
- P/E
- -0.78
- P/S
- 2219.29
- P/B
- -0.19
- EV/EBITDA
- -2.09
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -267.55%
- Op Margin
- -145500.21%
- Net Margin
- -267468.94%
- ROE
- 25.69%
- ROIC
- 14.02%
Growth & Income
- Revenue
- $1.21K · -12.18%
- Net Income
- $-2,505,854 · -12.49%
- EPS
- $-0.08 · 2.71%
- Op Income
- $-1,326,980
- FCF YoY
- 38.25%
Performance & Tape
- 52W High
- $0.17
- 52W Low
- $0.05
- 50D MA
- $0.07
- 200D MA
- $0.10
- Beta
- -0.00
- Avg Volume
- 5.39K
Get TickerSpark's AI analysis on ZRO.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ZRO.CN Coverage
We haven't published any research on ZRO.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ZRO.CN Report →